MELISSA FERGUSON: Open Payments
NPI 1376895318 · LAWRENCE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,166 in 64 payments from 17 companies in 2025. Trend: 2023 $1,057 · 2024 $1,541 · 2025 $1,166
Food & beverage: $1,166
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $252 |
| AstraZeneca Pharmaceuticals LP | 8 | $172 |
| ABBVIE INC. | 10 | $171 |
| Abbott Laboratories | 4 | $91 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| SHIELD THERAPEUTICS INC | 2 | $68 |
| Exact Sciences Corporation | 4 | $61 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| PFIZER INC. | 3 | $47 |
| Dexcom, Inc. | 2 | $31 |
Products named: Ozempic, AIRSUPRA, VRAYLAR, FREESTYLE LIBRE 3, Wegovy, REXULTI, ACCRUFER, Cologuard Collection Kit.
Industry payments across KS — which companies pay providers there.
